Microbix Historical Cash Flow
| MBX Stock | CAD 0.30 0.01 3.23% |
Analysis of Microbix Biosystems cash flow over time is an excellent tool to project Microbix Biosystems future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 1.1 M or Total Cash From Financing Activities of 250.4 K as it is a great indicator of Microbix Biosystems ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Microbix Biosystems latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Microbix Biosystems is a good buy for the upcoming year.
Microbix |
About Microbix Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Microbix balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Microbix's non-liquid assets can be easily converted into cash.
Microbix Biosystems Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Microbix Biosystems to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Microbix Biosystems operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Most accounts from Microbix Biosystems' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Microbix Biosystems current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Microbix Biosystems' Begin Period Cash Flow is very stable compared to the past year. As of the 3rd of December 2024, Other Cashflows From Financing Activities is likely to grow to about 140.2 K, though Change In Cash is likely to grow to (2.1 M).
Microbix Biosystems cash flow statement Correlations
Click cells to compare fundamentals
Microbix Biosystems Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Microbix Biosystems cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (2.9K) | 9.9M | 3.5M | (1.9M) | (2.2M) | (2.1M) | |
| Free Cash Flow | (805.3K) | 804.2K | 1.4M | (2.1M) | (2.4M) | (2.5M) | |
| Begin Period Cash Flow | 95.6K | 92.7K | 10.0M | 13.5M | 15.5M | 16.3M | |
| Other Cashflows From Financing Activities | (813.9K) | 2.2M | 3.4M | 105.3K | 121.0K | 140.2K | |
| Depreciation | 690.1K | 822.0K | 1.0M | 1.2M | 1.3M | 1.4M | |
| Other Non Cash Items | 3.4M | 892.0K | 330.5K | (2.7M) | (3.1M) | (3.0M) | |
| Capital Expenditures | 813.9K | 1.3M | 2.0M | 1.0M | 1.2M | 1.1M | |
| Total Cash From Operating Activities | 8.6K | 2.1M | 3.5M | (1.1M) | (1.3M) | (1.2M) | |
| Net Income | (6.2M) | 3.2M | 1.8M | (39.5K) | (45.4K) | (47.7K) | |
| Total Cash From Financing Activities | 802.4K | 8.4M | 2.1M | 229.2K | 263.6K | 250.4K | |
| End Period Cash Flow | 92.7K | 10.0M | 13.5M | 11.6M | 13.3M | 14.0M | |
| Change To Inventory | 187.5K | (114.8K) | (877.4K) | (467.1K) | (420.4K) | (399.4K) | |
| Change In Working Capital | 461.4K | (3.2M) | (340.1K) | (219.8K) | (197.9K) | (207.7K) | |
| Change To Account Receivables | (167.5K) | (2.3M) | 1.1M | (1.1M) | (955.8K) | (908.0K) | |
| Stock Based Compensation | 158.8K | 377.8K | 649.7K | 735.3K | 845.6K | 887.9K | |
| Sale Purchase Of Stock | 2.2M | 8.3M | 3.4M | (1.1M) | (1.3M) | (1.2M) | |
| Net Borrowings | 521.6K | (1.3M) | 83.8K | (1.4M) | (1.2M) | (1.2M) | |
| Total Cashflows From Investing Activities | (514.8K) | (813.9K) | (622.3K) | (2.0M) | (2.3M) | (2.4M) | |
| Change To Operating Activities | 70.8K | (120.9K) | (275.0K) | (51.3K) | (46.1K) | (48.5K) | |
| Change To Netincome | 372.3K | 5.1M | 1.3M | 980.2K | 1.1M | 1.1M | |
| Change To Liabilities | (570.3K) | 562.3K | (530.5K) | (528.7K) | (475.9K) | (452.1K) | |
| Investments | (813.9K) | (622.3K) | (2.0M) | (1.0M) | (914.6K) | (960.3K) | |
| Issuance Of Capital Stock | 2.2M | 2.2M | 6.1M | (6.4K) | (5.7K) | (5.4K) |
Pair Trading with Microbix Biosystems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.Moving against Microbix Stock
| 0.85 | AMZN | Amazon CDR | PairCorr |
| 0.81 | NVDA | NVIDIA CDR | PairCorr |
| 0.8 | TD-PFD | Toronto Dominion Bank Earnings Call This Week | PairCorr |
| 0.78 | BOFA | Bank of America | PairCorr |
| 0.72 | GOOG | Alphabet CDR | PairCorr |
The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.
The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Microbix Stock
The Cash Flow Statement is a financial statement that shows how changes in Microbix balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Microbix's non-liquid assets can be easily converted into cash.